AUSTRALIAN DRUG DEVELOPMENT BLOG
The Latest Blogs from Agilex Biolabs
Author By Jeremy BurtPosted on
Let's face it – we are an aging population throughout the world. More and more, we are seeing these neurological disorders growi...
Author By Jeremy BurtPosted on
In molecular biology and pharmacology, small molecules are noted for their ability to quickly modulate their actions. This is beca...
Author By Jeremy BurtPosted on
Applying Decades of Experience with an Eye on the Future of Small Molecule Development For decades before antibody drugs were d...
Author By Jeremy BurtPosted on
Looking beyond the surface on the Complexity of Atopic Dermatitis Addressing inflammatory skin disorders like atopic dermatitis...
Author By Jeremy BurtPosted on
We took some time to sit down and talk with Jason so you could get to know him a bit better... My name is Jason Valentine. I'm...
Author By Jeremy BurtPosted on
We took some time to sit down and talk with Cameron so you could get to know him a bit better... My name is Cameron Smith. I'm...
Author By Jeremy BurtPosted on
We took some time to sit down and talk with Dr Sales so you could get to know him a bit better... My name is Kurt Sales. I’m...
Author By Jeremy BurtPosted on
Unraveling the Untapped Potential of Immuno-Oncology Technology Both the pace and varied methods by which medical clinicians ut...
Author By Jeremy BurtPosted on
A Quick Look at Agilex Biolabs' Expertise and Capabilities In the intricate landscape of drug discovery and development, the as...
Author By Jeremy BurtPosted on
Agilex Biolabs has extensive knowledge on small molecule development and pharmacokinetic services. Today, pharmacokinetics (PK)...
Author By Jeremy BurtPosted on
Agilex Biolabs integrates critical reagents services into comprehensive lifecycle management. The relationship between producin...
Author By Jeremy BurtPosted on
Agilex is pleased to introduce Mallory Jolly as our new Senior Business Development Director to the East Coast of the United State...